We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna Corporation (CI) Hit a 52 Week High, Can the Run Continue?
Read MoreHide Full Article
Have you been paying attention to shares of Cigna (CI - Free Report) ? Shares have been on the move with the stock up 7.1% over the past month. The stock hit a new 52-week high of $277.45 in the previous session. Cigna has gained 20.1% since the start of the year compared to the -16.3% move for the Zacks Finance sector and the -5.4% return for the Zacks Insurance - Multi line industry.
What's Driving the Outperformance?
The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on May 6, 2022, Cigna reported EPS of $6.01 versus consensus estimate of $5.13 while it beat the consensus revenue estimate by 1.23%.
For the current fiscal year, Cigna is expected to post earnings of $22.68 per share on $177.75 billion in revenues. This represents a 10.8% change in EPS on a 2.11% change in revenues. For the next fiscal year, the company is expected to earn $25.26 per share on $186.76 billion in revenues. This represents a year-over-year change of 11.38% and 5.07%, respectively.
Valuation Metrics
Cigna may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Cigna has a Value Score of A. The stock's Growth and Momentum Scores are B and F, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 12.2X current fiscal year EPS estimates, which is a premium to the peer industry average of 9.6X. On a trailing cash flow basis, the stock currently trades at 9.2X versus its peer group's average of 7.2X. Additionally, the stock has a PEG ratio of 1.1. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Cigna currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cigna meets the list of requirements. Thus, it seems as though Cigna shares could have potential in the weeks and months to come.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cigna Corporation (CI) Hit a 52 Week High, Can the Run Continue?
Have you been paying attention to shares of Cigna (CI - Free Report) ? Shares have been on the move with the stock up 7.1% over the past month. The stock hit a new 52-week high of $277.45 in the previous session. Cigna has gained 20.1% since the start of the year compared to the -16.3% move for the Zacks Finance sector and the -5.4% return for the Zacks Insurance - Multi line industry.
What's Driving the Outperformance?
The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on May 6, 2022, Cigna reported EPS of $6.01 versus consensus estimate of $5.13 while it beat the consensus revenue estimate by 1.23%.
For the current fiscal year, Cigna is expected to post earnings of $22.68 per share on $177.75 billion in revenues. This represents a 10.8% change in EPS on a 2.11% change in revenues. For the next fiscal year, the company is expected to earn $25.26 per share on $186.76 billion in revenues. This represents a year-over-year change of 11.38% and 5.07%, respectively.
Valuation Metrics
Cigna may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Cigna has a Value Score of A. The stock's Growth and Momentum Scores are B and F, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 12.2X current fiscal year EPS estimates, which is a premium to the peer industry average of 9.6X. On a trailing cash flow basis, the stock currently trades at 9.2X versus its peer group's average of 7.2X. Additionally, the stock has a PEG ratio of 1.1. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks Rank
We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Cigna currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cigna meets the list of requirements. Thus, it seems as though Cigna shares could have potential in the weeks and months to come.